Elevated intraocular tension is one of the diagnostic requirements for glaucoma, and reducing intraocular force is often a goal of glaucoma treatments (Prum et al., 2016). The trial was evaluated as “unclear” hazard of bias. No dissimilarities in intraocular stress have been observed involving placebo and cannabinoids. This listing of https://kylercksyd.blogcudinti.com/32935352/detailed-notes-on-cannabis-bud